Evidence map›Paper›PMID 41683388›Full record

ReviewMolecules (Basel, Switzerland)2026

Black Gold in Medicine: Rediscovering the Pharmacological Potential.

Ulduz Hashimova, Aliya Gaisina, Khatira Safikhanova

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ulduz HashimovaInstitute of Physiology Named After Academician Abdulla Garayev, Ministry of Science and Education, AZ1100 Baku, Azerbaijan.ORCID 0000-0002-7740-0972
Aliya GaisinaInstitute of Physiology Named After Academician Abdulla Garayev, Ministry of Science and Education, AZ1100 Baku, Azerbaijan.ORCID 0000-0002-3435-9981
Khatira SafikhanovaInstitute of Physiology Named After Academician Abdulla Garayev, Ministry of Science and Education, AZ1100 Baku, Azerbaijan.ORCID 0009-0007-4986-3244

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores crude oil as a chemically and structurally heterogeneous system with potential pharmaceutical relevance beyond its established roles as an energy and feedstock resource. Recent advances in analytical technologies have enabled the detailed characterization of crude oil constituents at the molecular level, thereby linking structural features to physicochemical properties and possible biological activities. The presented analysis outlines the rationale, methodological considerations, and future research directions for integrating crude oil molecular motifs into the pharmaceutical chemical space. Beyond its conventional role as an industrial and energy resource, crude oil may also hold promise for drug discovery. This study seeks to provide a conceptual framework for reconsidering crude oil as a reservoir of pharmacologically relevant scaffolds and to outline methodological approaches for their systematic assessment. Its rigid sp

Indexed as

Drug DiscoveryPetroleumHumansPetroleumcrude oilNaftalan crudepetroleomicspetroleum biomarkerspetroleum-derived scaffoldssp3 scaffolds

Identifiers

PMID41683388
PMCPMC12898866

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.